Skip to main content

Table 2 Hazard ratio for the incidence of hyperuricemia by combining hypertension and hypertriglyceridemia status

From: Association of hypertension and hypertriglyceridemia on incident hyperuricemia: an 8-year prospective cohort study

 

Hazard Ratio (95% CI)

P-value for trend

Normotension and normal TG

Hypertension and normal TG

Normotension and HTG

Hypertension and HTG

Overalla

 

Model 1

1 (Ref.)

1.48 (1.28–1.71)

1.84 (1.55–2.18)

3.02 (2.60–3.50)

 < 0.001

Model 2

1 (Ref.)

1.39 (1.19–1.63)

1.80 (1.52–2.14)

2.88 (2.48–3.36)

 < 0.001

Model 3

1 (Ref.)

1.24 (1.05–1.46)

1.61 (1.34–1.93)

2.36 (2.00–2.78)

 < 0.001

Menb

 

Model 1

1 (Ref.)

1.28 (1.09–1.52)

1.58 (1.30–1.91)

2.63 (2.23–3.11)

 < 0.001

Model 2

1 (Ref.)

1.28 (1.08–1.51)

1.57 (1.29–1.91)

2.63 (2.22–3.11)

 < 0.001

Model 3

1 (Ref.)

1.17 (0.98–1.40)

1.43 (1.17–1.76)

2.22 (1.85–2.67)

 < 0.001

Womenb

 

Model 1

1 (Ref.)

2.06 (1.48–2.87)

2.77 (1.93–3.98)

4.16 (3.00–5.76)

 < 0.001

Model 2

1 (Ref.)

1.77 (1.23–2.56)

2.62 (1.82–3.78)

3.60 (2.52–5.16)

 < 0.001

Model 3

1 (Ref.)

1.57 (1.07–2.32)

2.36 (1.60–3.47)

2.76 (1.87–4.07)

 < 0.001

  1. aModel 1 was unadjusted baseline values of variables. Model 2 was adjustment for age and sex. Model 3 was further adjustment for body-mass index, eGFR, blood urea nitrogen and proteinuria
  2. bModel 1 was unadjusted baseline values of variables. Model 2 was adjustment for age. Model 3 was further adjustment for body-mass index, eGFR, blood urea nitrogen and proteinuria